Lamivudine and Zidovudine
NDC 33342-003, Lamivudine and Zidovudine, tablet, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-003
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090679
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE150 mg/1
- ZIDOVUDINE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-003-09 | 33342000309 | 60 TABLET in 1 BOTTLE (33342-003-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/63667952-be01-483e-9887-1d5417e7ec16NADAC price for package 33342000309
GET /v1/drugs/nadac/33342000309
Use it
Look up 33342-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.